David J. Bearss

Person

Modesto, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 12,338,261
- Issue date Jun 24, 2025
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK9 inhibitors
- Patent number 12,275,738
- Issue date Apr 15, 2025
- Biolexis Therapeutics, Inc.
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of NEK7 kinase
- Patent number 12,091,413
- Issue date Sep 17, 2024
- HALIA THERAPEUTICS, INC.
- David James Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of LRRK2 kinase
- Patent number 11,866,423
- Issue date Jan 9, 2024
- HALIA THERAPEUTICS, INC.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of acute myeloid leukemia (AML) with venetoclax failure
- Patent number 11,793,802
- Issue date Oct 24, 2023
- Sumitomo Pharma Oncology, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions comprising PKM2 modulators and methods of treatment us...
- Patent number 11,712,433
- Issue date Aug 1, 2023
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of NEK7 kinase
- Patent number 11,713,321
- Issue date Aug 1, 2023
- HALIA THERAPEUTICS, INC.
- David James Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of LRRK2 kinase
- Patent number 11,578,061
- Issue date Feb 14, 2023
- HALIA THERAPEUTICS, INC.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof
- Patent number 11,529,350
- Issue date Dec 20, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment regimen for cancers that are insensitive to BCL-2 inhibit...
- Patent number 11,497,756
- Issue date Nov 15, 2022
- Sumitomo Pharma Oncology, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
AXL kinase inhibitors and use of the same
- Patent number 11,400,091
- Issue date Aug 2, 2022
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of NEK7 kinase
- Patent number 11,161,852
- Issue date Nov 2, 2021
- HALIA THERAPEUTICS, INC.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating diseases associated with abnormal ACVR1 expres...
- Patent number 11,040,038
- Issue date Jun 22, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,835,537
- Issue date Nov 17, 2020
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK1 and ALK2 inhibitors and methods for their use
- Patent number 10,752,594
- Issue date Aug 25, 2020
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Alexis Mollard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,682,356
- Issue date Jun 16, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,624,880
- Issue date Apr 21, 2020
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- G01 - MEASURING TESTING
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,568,887
- Issue date Feb 25, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,562,925
- Issue date Feb 18, 2020
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,422,788
- Issue date Sep 24, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,357,488
- Issue date Jul 23, 2019
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,267,787
- Issue date Apr 23, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,259,835
- Issue date Apr 16, 2019
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK2 and ALK2 inhibitors and methods for their use
- Patent number 10,202,356
- Issue date Feb 12, 2019
- Tolero Pharmaceuticals, Inc.
- Alexis Mollard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,132,797
- Issue date Nov 20, 2018
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 9,901,574
- Issue date Feb 27, 2018
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosi...
- Patent number 9,828,376
- Issue date Nov 28, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 9,758,539
- Issue date Sep 12, 2017
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 9,642,857
- Issue date May 9, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...
- Patent number 9,555,024
- Issue date Jan 31, 2017
- University of Utah Research Foundation
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NEK7 INHIBITORS
- Publication number 20250177382
- Publication date Jun 5, 2025
- Halia Therapeutics, Inc.
- Alexis Henri Abel Mollard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL PROTAC AND MOLECULAR GLUE COMPOUNDS AND METHODS OF USE...
- Publication number 20250114357
- Publication date Apr 10, 2025
- Biolexis Therapeutics, Inc.
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS
- Publication number 20250019378
- Publication date Jan 16, 2025
- Halia Therapeutics, Inc.
- David James BEARSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TYRO3 INHIBITORS
- Publication number 20240425499
- Publication date Dec 26, 2024
- Halia Therapeutics, Inc.
- David James BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEK7 INHIBITORS
- Publication number 20240400551
- Publication date Dec 5, 2024
- Halia Therapeutics, Inc.
- Alexis Henri Abel Mollard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapies for Treatment of Myelodysplastic Syndrome
- Publication number 20240382473
- Publication date Nov 21, 2024
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEK7 INHIBITORS
- Publication number 20240382488
- Publication date Nov 21, 2024
- Halia Therapeutics, Inc.
- David James BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEK7 INHIBITORS
- Publication number 20240317758
- Publication date Sep 26, 2024
- Halia Therapeutics, Inc.
- David James BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF LRRK2 KINASE
- Publication number 20240190848
- Publication date Jun 13, 2024
- Halia Therapeutics, Inc.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEK7 INHIBITORS
- Publication number 20240158394
- Publication date May 16, 2024
- Halia Therapeutics, Inc.
- Ramesh Subbiah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK9 Inhibitors
- Publication number 20240150322
- Publication date May 9, 2024
- Biolexis Therapeutics, Inc.
- Hariprasad VANKAYALAPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE
- Publication number 20240083855
- Publication date Mar 14, 2024
- SUMITOMO PHARMA AMERICA, INC.
- Alexis MOLLARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME
- Publication number 20240075033
- Publication date Mar 7, 2024
- Sumitomo Pharma Oncology, Inc.
- David J. BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF NEK7 KINASE
- Publication number 20230416259
- Publication date Dec 28, 2023
- Halia Therapeutics, Inc.
- David James Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK9 INHIBITORS
- Publication number 20230322792
- Publication date Oct 12, 2023
- Biolexis Therapeutics, Inc.
- Hariprasad Vankayalapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME
- Publication number 20230210853
- Publication date Jul 6, 2023
- Halia Therapeutics, Inc.
- David James BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF NEK7 KINASE
- Publication number 20230203045
- Publication date Jun 29, 2023
- Halia Therapeutics, Inc.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF LRRK2 KINASE
- Publication number 20230183217
- Publication date Jun 15, 2023
- Halia Therapeutics, Inc.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20230165857
- Publication date Jun 1, 2023
- Sumitomo Pharma Oncology, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...
- Publication number 20220339172
- Publication date Oct 27, 2022
- Sumitomo Pharma Oncology, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF LRRK2 KINASE
- Publication number 20220324845
- Publication date Oct 13, 2022
- Halia Therapeutics, Inc.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Cancer
- Publication number 20220305037
- Publication date Sep 29, 2022
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer
- Publication number 20220257581
- Publication date Aug 18, 2022
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
- Publication number 20220125776
- Publication date Apr 28, 2022
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF NEK7 KINASE
- Publication number 20220064173
- Publication date Mar 3, 2022
- Halia Therapeutics, Inc.
- David James Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF NEK7 KINASE
- Publication number 20210355130
- Publication date Nov 18, 2021
- Halia Therapeutics, Inc.
- David James Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alvocidib Prodrugs Having Increased Bioavailability
- Publication number 20210261585
- Publication date Aug 26, 2021
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20210228582
- Publication date Jul 29, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL KINASE INHIBITORS AND USE OF THE SAME
- Publication number 20210205304
- Publication date Jul 8, 2021
- SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS AND METHODS FOR TREATING CANCER
- Publication number 20210145830
- Publication date May 20, 2021
- Mayo Foundation for Medical Education and Research
- Saad J. Kenderian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

David J. Bearss

Person

Patents Grantslast 30 patents

Alvocidib prodrugs having increased bioavailability

CDK9 inhibitors

Inhibitors of NEK7 kinase

Inhibitors of LRRK2 kinase

Treatment of acute myeloid leukemia (AML) with venetoclax failure

Compositions comprising PKM2 modulators and methods of treatment us...

Inhibitors of NEK7 kinase

Inhibitors of LRRK2 kinase

Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

Treatment regimen for cancers that are insensitive to BCL-2 inhibit...

AXL kinase inhibitors and use of the same

Inhibitors of NEK7 kinase

Methods for treating diseases associated with abnormal ACVR1 expres...

Combination therapies for treatment of cancer

JAK1 and ALK2 inhibitors and methods for their use

Combination therapies for treatment of cancer

Predicting response to alvocidib by mitochondrial profiling

Combination therapies for treatment of cancer

Alvocidib prodrugs having increased bioavailability

Profiling peptides and methods for sensitivity profiling

Predicting response to alvocidib by mitochondrial profiling

Profiling peptides and methods for sensitivity profiling

Alvocidib prodrugs having increased bioavailability

JAK2 and ALK2 inhibitors and methods for their use

Profiling peptides and methods for sensitivity profiling

Predicting response to alvocidib by mitochondrial profiling

Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosi...

Alvocidib prodrugs having increased bioavailability

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as hi...

Patents Applicationslast 30 patents

NEK7 INHIBITORS

BIFUNCTIONAL PROTAC AND MOLECULAR GLUE COMPOUNDS AND METHODS OF USE...

PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS

TYRO3 INHIBITORS

NEK7 INHIBITORS

Combination Therapies for Treatment of Myelodysplastic Syndrome

NEK7 INHIBITORS

NEK7 INHIBITORS

INHIBITORS OF LRRK2 KINASE

NEK7 INHIBITORS

CDK9 Inhibitors

JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE

ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME

INHIBITORS OF NEK7 KINASE

CDK9 INHIBITORS

TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME

INHIBITORS OF NEK7 KINASE

INHIBITORS OF LRRK2 KINASE

AXL KINASE INHIBITORS AND USE OF THE SAME

METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...

INHIBITORS OF LRRK2 KINASE

Treatment of Cancer

Treatment of Cancer

Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure

INHIBITORS OF NEK7 KINASE

INHIBITORS OF NEK7 KINASE

Alvocidib Prodrugs Having Increased Bioavailability

COMBINATION THERAPIES FOR TREATMENT OF CANCER

AXL KINASE INHIBITORS AND USE OF THE SAME

MATERIALS AND METHODS FOR TREATING CANCER